🇺🇸 FDA
Patent

US 7709007

Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences

granted A61KA61K39/00A61P

Quick answer

US patent 7709007 (Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
46
CPC classes
A61K, A61K39/00, A61P, A61P31/12, A61P31/14